SCHEMBL7424765

SCHEMBL7424765

NC(=O)CN1CCC(C(Cc2ccccc2)C(N)=O)C1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.41
DPP7 Q9UHL4 1/20 0.41
GAA P10253 2/20 0.41
TACR1 P25103 1/20 0.40
BACE1 P56817 1/20 0.40
EPHX1 P07099 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CHRM1 P11229 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
UBE2M P61081 1/20 0.38
DCUN1D1 Q96GG9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4180733 0.79 EPHX1 (0.51) DPP4TACR1EPHX1ALDH1A1CYP1A2
SCHEMBL18657232 0.74 GAA (0.58) GAAKDM4E
SCHEMBL6265947 0.74 EPHX1 (0.46) DPP4DPP7TACR1EPHX1CYP1A2
SCHEMBL4022907 0.74 EPHX1 (0.46) DPP4DPP7TACR1EPHX1CYP1A2
SCHEMBL27832973 0.72 CPN1 (0.45) DPP4TACR1EPHX1
SCHEMBL24652524 0.72 ALDH1A1 (0.57) GAAALDH1A1TSHR
SCHEMBL3165125 0.72 ALDH1A1 (0.57) GAAALDH1A1TSHR
SCHEMBL4281407 0.71 GAA (0.64) GAAALDH1A1KDM4E
SCHEMBL4156781 0.70 EPHX1 (0.43) TACR1EPHX1
SCHEMBL4156782 0.70 EPHX1 (0.43) TACR1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0898562-A1 HYDROXAMIC ACID DERIVATIVES FOR USE WITH THE TREATMENT OF DISEASES RELATED TO CONNECTIVE TISSUE DEGRADATION PHARMACIA & UPJOHN COMPANY (US) 1999-03-03 EP disclosed
WO-1997032846-A1 HYDROXAMIC ACID DERIVATIVES FOR USE WITH THE TREATMENT OF DISEASES RELATED TO CONNECTIVE TISSUE DEGRADATION PHARMACIA & UPJOHN COMPANY (US) 1997-09-12 WO disclosed